BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 226 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q2 2021. The put-call ratio across all filers is 1.19 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $11,629,000 | +2.6% | 76,928 | -1.1% | 0.02% | +11.1% |
Q2 2022 | $11,336,000 | +29.2% | 77,801 | +5.2% | 0.02% | +50.0% |
Q1 2022 | $8,771,000 | -20.6% | 73,976 | -7.7% | 0.01% | -7.7% |
Q4 2021 | $11,042,000 | +1.8% | 80,127 | +2.6% | 0.01% | -7.1% |
Q3 2021 | $10,851,000 | +40.5% | 78,118 | -1.8% | 0.01% | +40.0% |
Q2 2021 | $7,725,000 | +45.6% | 79,578 | +2.5% | 0.01% | +42.9% |
Q1 2021 | $5,307,000 | -20.5% | 77,648 | -0.3% | 0.01% | -22.2% |
Q4 2020 | $6,676,000 | +31.9% | 77,889 | +0.1% | 0.01% | +12.5% |
Q3 2020 | $5,060,000 | -2.7% | 77,837 | +9.4% | 0.01% | -11.1% |
Q2 2020 | $5,201,000 | +135.0% | 71,139 | +9.4% | 0.01% | +80.0% |
Q1 2020 | $2,213,000 | -31.9% | 65,023 | +8.8% | 0.01% | -16.7% |
Q4 2019 | $3,252,000 | +27.9% | 59,740 | -2.0% | 0.01% | +20.0% |
Q3 2019 | $2,543,000 | +13.3% | 60,947 | +18.9% | 0.01% | +25.0% |
Q2 2019 | $2,245,000 | -8.8% | 51,260 | +7.2% | 0.00% | -20.0% |
Q1 2019 | $2,462,000 | +49.6% | 47,832 | +7.5% | 0.01% | +25.0% |
Q4 2018 | $1,646,000 | +0.9% | 44,502 | +2.4% | 0.00% | +33.3% |
Q3 2018 | $1,632,000 | -1.3% | 43,468 | +3.9% | 0.00% | 0.0% |
Q2 2018 | $1,653,000 | +32.7% | 41,835 | -13.5% | 0.00% | 0.0% |
Q1 2018 | $1,246,000 | +176.3% | 48,371 | +189.6% | 0.00% | +200.0% |
Q4 2017 | $451,000 | -29.0% | 16,700 | -1.8% | 0.00% | 0.0% |
Q3 2017 | $635,000 | +43.3% | 17,000 | -4.0% | 0.00% | 0.0% |
Q2 2017 | $443,000 | – | 17,700 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Knoll Capital Management, LLC | 710,422 | $24,658,747 | 16.62% |
Birchview Capital, LP | 7,365 | $255,639 | 0.24% |
Itau Unibanco Holding S.A. | 88 | $3,054 | 0.00% |